Doximity Inc
NYSE:DOCS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
43.49
83.14
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
DOCS
stock under the Base Case scenario is
33.66
USD.
Compared to the current market price of 43.65 USD,
Doximity Inc
is
Overvalued by 23%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Doximity Inc.
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
|
| US |
C
|
Cerner Corp
LSE:0R00
|
|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
|
| JP |
|
M3 Inc
TSE:2413
|
|
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
|
| SE |
|
Sectra AB
STO:SECT B
|
|
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
|
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
|
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
|
| US |
V
|
Vocera Communications Inc
F:V00
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Doximity’s heavy reliance on targeted advertising revenue from pharmaceutical and hospital partners could become vulnerable if marketing budgets tighten or regulatory scrutiny of digital pharma ads heightens, potentially reducing the platform’s most important revenue stream.
The company’s strong user base among medical professionals could stagnate if competing physician-focused platforms or broader telehealth solutions offer similar networking tools without the subscription cost, undermining Doximity’s prime differentiator.
Data privacy concerns or a high-profile breach of sensitive physician and patient information could erode trust in the platform, disrupting both user engagement and monetization opportunities in a market where compliance is paramount.
Doximity’s deep network of U.S. physicians and healthcare providers confers a unique competitive advantage, creating a valuable, specialized user base that new entrants or traditional social networks like LinkedIn find difficult to replicate.
Management’s focus on integrating telehealth infrastructure, such as Dialer and scheduling tools, sets the company up to capitalize on shifting provider preferences and patient demand for convenient and secure virtual care solutions.
By leveraging its large, loyal community of verified medical professionals, Doximity stands to expand revenue streams beyond advertising and telehealth—potentially into continuing medical education, physician recruitment services, and collaboration with electronic health record (EHR) providers.
Revenue & Expenses Breakdown
Doximity Inc
Balance Sheet Decomposition
Doximity Inc
| Current Assets | 1.1B |
| Cash & Short-Term Investments | 878.4m |
| Receivables | 140.6m |
| Other Current Assets | 73.2m |
| Non-Current Assets | 164.9m |
| PP&E | 23.7m |
| Intangibles | 124.1m |
| Other Non-Current Assets | 17.1m |
| Current Liabilities | 140.3m |
| Accounts Payable | 4.4m |
| Accrued Liabilities | 17.3m |
| Other Current Liabilities | 118.6m |
| Non-Current Liabilities | 21.3m |
| Other Non-Current Liabilities | 21.3m |
Free Cash Flow Analysis
Doximity Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Doximity Inc
|
Revenue
|
621.3m
USD
|
|
Cost of Revenue
|
-60.9m
USD
|
|
Gross Profit
|
560.5m
USD
|
|
Operating Expenses
|
-313.7m
USD
|
|
Operating Income
|
246.8m
USD
|
|
Other Expenses
|
6.2m
USD
|
|
Net Income
|
253m
USD
|
DOCS Profitability Score
Profitability Due Diligence
Doximity Inc's profitability score is 75/100. The higher the profitability score, the more profitable the company is.
Score
Doximity Inc's profitability score is 75/100. The higher the profitability score, the more profitable the company is.
DOCS Solvency Score
Solvency Due Diligence
Doximity Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Doximity Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DOCS Price Targets Summary
Doximity Inc
According to Wall Street analysts, the average 1-year price target for
DOCS
is 69.67 USD
with a low forecast of 55.55 USD and a high forecast of 87.15 USD.
Dividends
Current shareholder yield for
DOCS is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
DOCS
stock under the Base Case scenario is
33.66
USD.
Compared to the current market price of 43.65 USD,
Doximity Inc
is
Overvalued by 23%.